Patent details
301102
Product Name:
combinatie van formoterol (met inbegrip van de farmaceutisch aanvaardbare zouten, esters, solvaten of enantiomeren ervan), glycopyrrolaat (met inbegrip van de farmaceutisch aanvaardbare zouten, esters, solvaten of enantiomeren ervan) en budesonide (met inbegrip van de farmaceutisch aanvaardbare zouten, esters, solvaten of enantiomeren ervan)
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301102
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2435024
Status:
Application Pending
Application number:
301102
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/20/1498
Marketing Authorization Type:
EEA
Marketing Authorization Date:
10/12/2020
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
10/05/2021
First Marketing Authorization date:
10/12/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/05/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
10/05/2021
Name:
Pearl Therapeutics, Inc.
Address:
200 Saginaw Drive, Redwood City, CA 94063, United States of America (US)
Agent
1
Name:
dr. R.C. van Duijvenbode c.s.
From:
07/11/2025
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
2
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
10/05/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
07/11/2025
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
19/21
Publication date:
17/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
11/05/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/6/5/6/2/8/0800682656/docs/301102_3_411037l174.pdf
10/05/2021
SPC Documents
Annex SPC
2
PDF
/6/5/6/2/8/0800682656/docs/301102_0_supplprotectioncertificate20210511082750463.pdf
10/05/2021
SPC Documents
Summary of the characteristics of the product
17
PDF
/6/5/6/2/8/0800682656/docs/301102_1_supplprotectioncertificate20210511082904539.pdf
10/05/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/6/5/6/2/8/0800682656/docs/301102_2_supplprotectioncertificate20210511082719405.pdf
10/05/2021
Application Form
First filed application form
3
PDF
/6/5/6/2/8/0800682656/docs/301102_4_applicationform20210511082504623.pdf